| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |